Latest: India Glycols Ltd Q1 FY27 results →All Q3 FY26 results →
G

India Glycols Ltd

Q3 FY26Beverages

India Glycols Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹1,146
Market cap₹7.1K Cr
P/E22.4
Updated23 Aug 2026
Read4 min read

The short version

Potable Spirits segment expects volume growth of about 5% year-on-year with revenue growth around 16.6%, driven by a premiumization strategy and product innovation. Chemicals segment margins improved from 11% to 15% and expected to sustain or improve further due to portfolio optimization and operational efficiencies.

From India Glycols Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Potable Spirits segment expects volume growth of about 5% year-on-year with revenue growth around 16.6%, driven by a premiumization strategy and product innovation.
  • New product launches in premium single malt, rum, brandy, and regular potable spirits are expanding market presence and geographic reach, including Kerala and paramilitary markets.
  • Biofuels segment shows strong growth with revenue up 45.2% in Q3 and 51.2% for 9 months, expecting continued expansion driven by ethanol blending targets in India.
  • Performance Chemicals and Bio-based Specialty Chemicals anticipate growth through new product introductions and expanded capacity, including bio-based amines sold globally.
  • Ennature Biopharma segment, though currently under pressure, is focusing on branded portfolios with innovative formulations expected to improve margins and sales.

2 more points from India Glycols Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what India Glycols Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • No significant large-sized capex planned currently; any major capex will be undertaken only after the completion of the demerger.
  • Efforts are focused on debt prepayment and reducing interest costs rather than heavy capital expenditure at this stage.
  • Ongoing investments related to business expansion, such as establishing an office in Houston for branded nutraceuticals and launching new products like Gingeren and Asparagine.

2 more points from India Glycols Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Beverages

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 3
2Varun Beverages
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 3Mar 1
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what India Glycols Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Relevant insights related to business pipeline and demand include: - Strong pipeline of over 30-40 approved chemicals products under development for performance chemicals segment. - Discussions ongoing with multiple customers for bio-based amines and other performance chemicals. - Engagements with global and domestic clients including L'Oréal, BSF, Dove, with long gestation periods to scale volumes. - Positive outlook on scaling up bio-based amines, now in initial commercial sales. - Biofuels segment poised for growth driven by India's ethanol blending targets.

2 more points from India Glycols Ltd's call on order book

Create a free account to keep reading this call

India Glycols Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹976 Cr, net profit ₹87 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Beverages this season

  • Allied Blenders (Q3 FY26)

    Post UK FTA**: Opportunity to enter and profitably participate in the value Scotch segment (about 50% of luxury segment volumes), currently untapped. Key…

  • Piccadily Agro Industries Ltd (Q3 FY26)

    Q3 FY2025-26 total income: ₹315.2 crore, up 51.3% YoY (Page 6) . Key investor presentation takeaways from Piccadily Agro Industries Ltd's Q3 FY26 investor prese

  • United Breweries Ltd (Q3 FY26)

    January 2026 showed positive early signs with category growth rebounding to 4%-5%. Key concall takeaways from United Breweries's Q3 FY26 earnings call — and…

  • United Spirits Ltd (Q3 FY26)

    Marketing reinvestment rate was higher in the recent quarter (14% of net sales), normalizing to about 10.6% for the 9-month fiscal period, reflecting…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

India Glycols Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were India Glycols Ltd Q3 FY26 results?

Potable Spirits segment expects volume growth of about 5% year-on-year with revenue growth around 16.6%, driven by a premiumization strategy and product innovation. Chemicals segment margins improved from 11% to 15% and expected to sustain or improve further due to portfolio optimization and operational efficiencies.

What is India Glycols Ltd share price analysis?

India Glycols Ltd currently shows a neutral. The stock trades at a P/E of 22.4 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.

Is India Glycols Ltd planning capital expenditure?

No significant large-sized capex planned currently; any major capex will be undertaken only after the completion of the demerger.

Keep India Glycols Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.